Clinical Trial 48291

Sugar Land, TX 77478


Type II Diabetes Inadequately Controlled with Daily Basal Insulin - Sugar Land TX
Click image to enlarge

A 52 week study comparing the efficacy and safety of once weekly IcoSema and daily insulin glargine 100 units/mL combined with Insulin aspart, both treatment arms with or without oral antidiabetic drugs, in participants with Type 2 daibetes in inadequately controlled with daily basal insulin.


Need to be above the age of 18 years of age.

HbA1c needs to be between 7.0-10.0%

Treated with once daily or twice daily basal insulin use of 20 - 80 units/day. The treatment can be with or without any of the anti-diabetic drugs with stable doses.

Body mass index < 40.0 kg/m.

Qualified Participants May Receive:

Free study related materials, diet and exercise counseling, lab tests, investigational product, and compsensation for your time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.